Fortis Healthcare Limited announced the appointment of Mr. Lim Tsin-Lin (DIN:10118906), as an Additional Director (Non-Executive & Non-Independent) of the Company with effect from May 4, 2023. Mr. Lim Tsin-Lin would hold office upto the date of the ensuing Annual General Meeting of the Company and liable to retire by rotation. However, as per regulation 17(1C) of SEBI LODR, the Company shall ensure that the approval of shareholders for appointment of Mr. Lim Tsin- Lin on the Board of the Company is taken at the next general meeting or within 3 months, whichever is earlier.

Mr. Lim Tsin-Lin, aged 44 years, was appointed to the Board of IHH Healthcare Berhad in February 2023. Mr. Lim Tsin-Lin is currently the Head of Healthcare and Head of Dana Impak of Khazanah Nasional Berhad (Khazanah). He was a key member of the team that set up Khazanah's first foreign office in Beijing in 2008 and was subsequently appointed Head of China in 2017.

After serving 13 years overseas, he returned to Malaysia in 2021 to assume his current role in Khazanah. Prior to Khazanah, he was with Ernst & Young, Rating Agency Malaysia Bhd and ECM Libra Securities Sdn Bhd. Mr. Lim Tsin-Lin is a Chartered Financial Analyst (CFA) and holds Master in Business Administration from the MIT Sloan Fellows Programme, the Massachusetts Institute of Technology, United States and Bachelor of Commerce and Management from Lincoln University, New Zealand.